Story Navigation
-
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: LEE011 – a popular combination partnerDiscovery
-
Novartis Institutes for BioMedical ResearchCancer cocktails: LJM716 – closing a common release valve
-
DiscoveryNovartis Institutes for BioMedical ResearchCancer cocktails: ABL001 – hitting one target twiceDiscovery
-
From Our LabsAccess to HealthcareDigitalEmerging TechnologyMobile DevicesmHealth: A revolution in healthcare
Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
From Our Labs -
Patient PerspectivesDisease AwarenessLiving With DiseasePatient EducationExperts call for new approach to patient and physician management of type 2 diabetes
A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.
Patient Perspectives -
From Our LabsNovartis Institutes for BioMedical ResearchWhy Novartis scouts for disruptive technology
Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.
From Our Labs -
Patient PerspectivesDisease AwarenessHeart FailureLiving With DiseasePatient EducationMost Europeans have limited awareness about heart failure
The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.
Patient Perspectives -
From Our LabsDigitalDrug DiscoveryEmerging TechnologyFuture of HealthcareInnovationRobots speed the pace of modern drug discovery
Novartis researchers use automation to rapidly identify starting points for new drugs.
From Our Labs -
Patient PerspectivesChronic IllnessHeart FailureLiving With DiseasePatient EducationLiving with heart failure
Heart failure affects 26 million people worldwide. More people die from heart failure than from some advanced cancers, including breast and bowel cancer.
Patient Perspectives -
Access to HealthcareChildren's HealthDisease EradicationMalariaNovartis Malaria InitiativeNovartis Social Business2 million kids receive malaria medicine
Ahead of World Malaria Day, Novartis and Malaria No More delivered 2 million pediatric antimalarials to Zambia provided through the Power of One campaign.
Access to Healthcare -
Access to HealthcareAccess to HealthcareDisease EradicationEye CareSocial CommitmentSight savers jet to the rescue
Up the stairs to the entrance of the plane they climb: small children with cloudy eyes, teens with thick glasses and practiced squints, adults with dark shades.
Access to Healthcare -
From Our LabsDigitalEthical BusinessMedicine SafetySleuths use hi-tech sensors to fight pharmaceutical crime
Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.
From Our Labs
Pagination
- ‹ Previous page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- › Next page